Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice

PURPOSE: This study aimed to evaluate the efficacy and tolerability of dapagliflozin as an add-on or a switch therapy to lobeglitazone plus metformin (MFM) in Korean patients with inadequately controlled type 2 diabetes mellitus (T2DM) in real-world clinical practice. MATERIALS AND METHODS: The stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Da Hea, Suh, Young Ju, Cho, Yongin, Ahn, Seong Hee, Seo, Seongha, Hong, Seongbin, Lee, Yong-ho, Choi, Young Ju, Lee, Eunjig, Kim, So Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424781/
https://www.ncbi.nlm.nih.gov/pubmed/36031782
http://dx.doi.org/10.3349/ymj.2022.63.9.825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424781/
https://www.ncbi.nlm.nih.gov/pubmed/36031782
http://dx.doi.org/10.3349/ymj.2022.63.9.825

Ejemplares similares